Saturday, 29 January, 2022
HomeHealthJohnson & Johnson seeks nod to conduct vaccine trails for 12-17 age...

Johnson & Johnson seeks nod to conduct vaccine trails for 12-17 age group in India

Earlier in August, the US pharma giant Johnson & Johnson was given emergency use approval in India for its single-dose Covid-19 vaccine.

Text Size:

New Delhi: US pharma giant Johnson & Johnson has moved an application before the Central Drugs Standard Control Organisation (CDSCO) in India, seeking permission to conduct clinical trials of its single-dose Janssen vaccine against COVID-19 on adolescents (children of age group 12-17 years).

Earlier in August, Johnson & Johnson’s was given emergency use approval in India for its single-dose COVID-19 vaccine. A statement by Johnson & Johnson read, “On August 17, 2021, we submitted an application to the Central Drugs Standard Control Organisation (CDSCO) to conduct a study of the Johnson & Johnson COVID-19 vaccine in India in adolescents aged 12 – 17 years.”

“To ultimately achieve herd immunity, it is imperative that COVID-19 vaccine clinical trials continue to move forward in this population, and we remain deeply committed to the critical work needed to make our COVID-19 vaccine equitably accessible for all age groups,” the company’s spokesperson said.

The five vaccines which were granted emergency use authorisation in India are Serum Institute’s Covishield, Bharat Biotech’s Covaxin, Russia’s Sputnik V, Moderna and Now Johnson & Johnson (J&J).


Also read: Johnson & Johnson’s Covid vaccine gets emergency use approval in India


 

Subscribe to our channels on YouTube & Telegram

Why news media is in crisis & How you can fix it

India needs free, fair, non-hyphenated and questioning journalism even more as it faces multiple crises.

But the news media is in a crisis of its own. There have been brutal layoffs and pay-cuts. The best of journalism is shrinking, yielding to crude prime-time spectacle.

ThePrint has the finest young reporters, columnists and editors working for it. Sustaining journalism of this quality needs smart and thinking people like you to pay for it. Whether you live in India or overseas, you can do it here.

Support Our Journalism

Most Popular

×